Anti Obesity

Anti Obesity - most related articles:

- Review policies for childhood obesity, US - 3.6
- Taranabant for obesity discontinued by Merck - 3.3
- Drugs for epilepsy increases fracture risk in older - 2.9
- Zydus Cadila files IND with DCGI to treat diabetes - 2.9
- Herpes zoster or shingles risk more with rheumatoid arthritis medicines - 2.8
- Soluble fiber boosts immune system and immunity - 2.8
- Treating obesity with brown fat in the body - 2.8
- Obesity increased in USA, obesity policies are failing - 2.7
- Obesity enhances liver cancer risk - 2.6
- Obesity epidemic taking root in Africa - 2.5

Anti Obesity articles

Obesity epidemic in United States underestimated
The scope of the obesity epidemic in the United States has been greatly underestimated. Researchers found that the Body Mass Index (BMI) substantially under-diagnoses obesity when compared to the Dual Energy X-ray Absorptiometry (DXA) scan, a direct simultaneous measure of body fat, muscle mass, and bone density.

Review policies for childhood obesity, US
Before developing specific anti-obesity strategies, lawmakers and advocates should review the evidence on program effectiveness and costs in order to avoid policies that either won't work or will waste money.

Food aromas may prevent overeating helping obese
A real possibility does exist for developing a new generation of foods that make people feel full by releasing anti-hunger aromas during chewing, scientists in the Netherlands are reporting after a review of research on that topic.

Ghrelin can slow Parkinson's disease
Stomach hormone - Ghrelin - may be used to boost resistance to, or slow, the development of Parkinson's disease, Yale School of Medicine researchers report in a study published in the Journal of Neuroscience.

Treating obesity with brown fat in the body
Researchers have shown that they can produce brown fat, a natural energy-burning type of fat that counteracts obesity. If such a strategy can be developed for use in people, it could open a novel approach to treating obesity and diabetes.

Zydus Cadila files IND with DCGI to treat diabetes
Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies, has filed IND (Investigational New Drug) application for anti diabetic and anti obesity drug with Drugs Controller General of India (DCGI).

6 Anti Obesity articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.69